InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-11.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Yang Rick, 管理人员. Director active across 6 companies, notably Monte Rosa Therapeutics, Inc.. Aggregated, 7 reports have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €3.8m. History available since 17 July 2023. The latest transaction was disclosed on 10 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Yang Rick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
7 条申报中的 7 条
About Yang Rick
Rick Yang is a key member of Monte Rosa Therapeutics, Inc. Although his specific role is not detailed, he contributes to the strategic direction of the company, which focuses on developing innovative therapies. Rick brings valuable expertise in the biopharmaceutical field, helping Monte Rosa advance its mission to transform healthcare. His commitment to innovation and operational excellence is essential for the company's success.
